Vice Director at the Department of Neurology and Medical Psychology at the University of São Paulo
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"Cannabis as a medicine was used before the Christian era in Asia, mainly in India. The introduction of cannabis in the Western medicine occurred in the midst of the 19th century, reaching the climax in the last decade of that century, with the availability and usage of cannabis extracts or tinctures. In the first decades of the 20th century, the Western medical use of cannabis significantly decreased largely due to difficulties to obtain consistent results from batches of plant material of different potencies. The identification of the chemical structure of cannabis components and the possibility of obtaining its pure constituents were related to a significant increase in scientific interest in such plant, since 1965. This interest was renewed in the 1990's with the description of cannabinoid receptors and the identification of an endogenous cannabinoid system in the brain. A new and more consistent cycle of the use of cannabis derivatives as medication begins, since treatment effectiveness and safety started to be scientifically proven."
"History of Cannabis as a Medicine: A Review," Revista Brasileira de Psiquiatria, June 2006
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Vice Director, Department of Neurology, Psychiatry and Medical Psychology, FMRP, University of São Paulo (Brazil), unknown-present
President, Commission of University Activities, University of São Paulo, unknown-present
President, Commission for the Growth of Physiotherapy and Occupational Therapy Courses, University of São Paulo, unknown-present
"Cannabidiol: From an Inactive Cannabinoid to a Drug With Wide Spectrum of Action," Revista Brasileira de Psiquiatria, Apr. 17, 2008
"History of Cannabis as a Medicine: A Review," Revista Brasileira de Psiquiatria, 2006
Cowritten with J.A.S. Crippa, J.E.C. Hallak, F.A. Moreira, and F.S. Guimarães, "Cannabidiol, a Cannabis Sativa Constituent, as an Antipsychotic Drug," Brazilian Journal of Medical and Biological Research, 2006
Co-author, "Brain Effects of Cannabis--Neuroimaging Findings," [Article in Portuguese] Revista Brasileira de Psiquiatria, 2005
Co-author, "Cannabidiol Increases Fos Expression in the Nucleus Accumbens but not in the Dorsal Striatum," Life Sciences, 2004
Co-author, "Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow," Neuropsychopharmacology, 2004